5:46 PM
Apr 08, 2010
 |  BC Extra  |  Financial News

Biocartis raises EUR 30M, partners with Debiopharm

Diagnostic company Biocartis S.A. (Lausanne, Switzerland) raised EUR 30 million ($40.5 million) in a series B round. New investors Debiopharm S.A. (Lausanne, Switzerland) and Johnson & Johnson Development Corp. joined existing investors Aescap;...

Read the full 156 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >